ST
HALO icon

Smithfield Trust’s Halozyme HALO Stock Holding History

Smithfield Trust’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-129
Closed -$7K – 1061
2024
Q3 		$7K Buy
+129
New +$7.39K ﹤0.01% 893
2023
Q2 		– Sell
-1,070
Closed -$40K – 1025
2023
Q1 		$40K Buy
1,070
+240
+29% +$11.3K ﹤0.01% 564
2022
Q4 		$47K Buy
+830
New +$42.5K ﹤0.01% 517

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Smithfield Trust's HALO Position: Q4 2024 in Review

Smithfield Trust sold out of Halozyme (HALO) in Q4 2024, closing a stake of 129 shares — an estimated $7K sold.

Smithfield Trust first reported a position in HALO in Q4 2022 and held it in 3 quarters. The position peaked at $47K in Q4 2022. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • Smithfield Trust reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • Smithfield Trust sold 129 Halozyme shares in Q4 2024, an estimated $7K.
  • Smithfield Trust first reported a position in Halozyme in Q4 2022 and held it in 3 quarters.
  • Smithfield Trust's Halozyme position peaked at $47K in Q4 2022.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on Smithfield Trust's 13F filing for Q4 2024, filed 6 Feb 2025.